Shedding growth factors in cardiac hypertrophy

Nature Medicine

Volumn 8, Issue 1, 2002, Pages 20-21

  Liao, James K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM 12 PROTEINASE; DISINTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ADAM PROTEINS; CARDIOMEGALY; DISINTEGRINS; EPIDERMAL GROWTH FACTOR; GTP-BINDING PROTEINS; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0036152888     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0102-20     Document Type: Short Survey

References (12)

1. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
2. Signaling pathways for cardiac hypertrophy and failure
3. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloprotease inhibitors as a potential new therapy for cardiac hypertrophy
4. ADAMs: Focus on the protease domain
5. EGF receptor transactivation by G-protein-coupled receptors requires metalloprotease cleavage of proHB-EGF
6. Cloning of a disintegrin metalloprotease that processes precursor tumour-necrosis factor-α
7. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor α therapy
8. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload
9. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes
10. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
11. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
12. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors